<DOC>
	<DOCNO>NCT02204813</DOCNO>
	<brief_summary>There mark long-lasting improvement glucose homeostasis follow Roux-en-y gastric bypass surgery ( RYGB ) humans . This improvement attribute large part intestinal hormone , call GLP-1 , release circulation immediately eat . The purpose study determine GLP-1 mediates beneficial effect RYGB surgery glucose homeostasis human .</brief_summary>
	<brief_title>To Define Role GLP-1 Improving Glucose Homeostasis Humans Following Gastric Bypass Surgery</brief_title>
	<detailed_description>To conduct study , enroll human previously underwent Roux-en-Y gastric bypass surgery , medically weight stable sign type 2 diabetes either surgery . Potential subject first screen eligibility also verify safely participate study . Each study subject administer meal tolerance test ( MTT ) 3 separate occasion . For MTT , liquid meal ( Boost Plus ) ingest follow overnight fast . A primed-continuous infusion vehicle alone ( human albumin ) xenin-25 alone ( dose 4 12 pmoles x kg-1 x min-1 ) initiate 15 minute meal ingest . Blood sample collect MTT measurement glucose insulin level , well host hormone . A comparison result tell u effect xenin-25 insulin release mediate GLP-1 human .</detailed_description>
	<criteria>Individuals must able consent participation ( mental impairment affect cognition willingness follow study instruction ) . Healthy , weight stable , previous RouxenY gastric bypass surgery clinical evidence type 2 diabetes either RouxenY gastric bypass surgery . Women childbearing potential must currently taking/using method birth control acceptable investigator . A pregnancy test do begin visit . Any woman positive pregnancy test remove study . Willingness return 810ml blood drawn 2530 day last Xenin infusion ; check Xenin peptide antibody MAY develop . ( All effort make complete visit study participation . ) Lacks cognitive ability sign consent &amp; /or follow study direction . Women unwilling comply use acceptable method contraception course study , currently breastfeed . Volunteers history Acute Pancreatitis . Volunteers history cancer ( except skin cancer ) . Volunteer history Chronic Pancreatitis and/or risk factor chronic pancreatitis include hypertriglyceridemia ( triglyceride &gt; 400mg/ml ) hypercalcemia ( blood calcium level &gt; 11.md/dl ) and/or presence gallstone . Subjects take medication know affect glucose tolerance . Hematocrit lab 33 % ( finger stick hemoglobin measure HemoCue 201+ &lt; 11.2 g/dl ) . Any major medical condition , condition opinion PI make subject unsuitable study . Subjects abnormal kidney function measure Creatinine concentration exclude . Subjects history active liver disease AST/ALT level &gt; 2X upper limit normal also exclude . Total Bilirubin level &lt; 2 . Subjects unwilling allow use blood albumin preparation peptide . ( The blood prevent stick peptide tubing ; alternative method seek find . ) Unwillingness return 810ml blood drawn 2530 day last Xenin infusion ; check Xenin peptide antibody MAY develop . ( All effort make complete visit study participation . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Gastric Bypass</keyword>
	<keyword>RYGB</keyword>
	<keyword>GLP-1</keyword>
	<keyword>Xenin</keyword>
	<keyword>Insulin Secretion</keyword>
	<keyword>Glucose Homeostasis</keyword>
	<keyword>Vertical Sleeve</keyword>
	<keyword>Lap Band</keyword>
</DOC>